乳腺癌的预防他莫昔芬(Tamoxifen)他莫昔芬是一种雌激素受体的部分激动剂,可以显著降低患有早期乳腺癌妇女对侧乳腺癌的发病率。对相关研究分析发现雌激素受体阳性的患者使用他莫昔芬后对侧乳腺癌发病率降低了一半,而雌激素受体阴性的患者使用该药后对侧乳腺癌的发病率与对照组 Prevention of Breast Cancer Tamoxifen Tamoxifen is a partial agonist of the estrogen receptor and can significantly reduce the incidence of contralateral breast cancer in women with early-stage breast cancer. Related research analysis found that estrogen receptor-positive patients with tamoxifen contralateral breast cancer incidence decreased by half, while the estrogen receptor-negative patients with the drug contralateral breast cancer incidence and control group